-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new version of the "Drug Administration Law" clearly stipulates counterfeit drugs and inferior drugs, and greatly increases the cost of illegal dru.
For those who produce and sell inferior drugs, the illegally produced and sold drugs and illegal income will be confiscated, and the illegal production and sales will be punish.
A fine of not less than ten times but not more than 20 times the value of the drugs in question; for producing or selling counterfeit drugs, or producing or selling inferior drugs and the circumstances are serious, the legal representative, the main responsible person, the directly responsible person in charge and other responsible persons shall be fined , confiscate the income obtained from the unit during the period of the illegal act, impose a fine of not less than 30% but not more than three times the income obtained, and prohibit the production and operation of pharmaceuticals for li.
Recently, a number of pharmaceutical companies have been fined for producing and selling inferior drugs, many of which are large chains, and the illegal cost of tens of thousands of dollars has made the industry alarm bells sound aga.
Recently, an administrative punishment information released by Credit Guangzhou showed that a branch of a pharmaceutical company in Guangzhou was deemed to have failed sampling inspections of multiple batches of products such as “Korean Ginseng”, “Selected Chenpi” and “Sanqi” that were produced and so.
Inferior drugs, fined 190,000 yu.
Not long ago, a branch of a large chain pharmacy in Guangdong was fined 3,000 yuan for "failure to display medical devices and non-medical device products separately, clearly separate them, or set up clearly distinguishable labels"; Penalty information shows that the above-mentioned large chain pharmacy branch was fined 100,000 yuan for producing and selling inferior dru.
In early May, the Putian Municipal Bureau of Supervision issued an administrative penalty decision to punish a pharmacy in the Chengxiang District of Putian Ci.
The penalty decision shows that, as a drug dealer, the pharmacy failed to implement the drug inspection system and drug management quality management standards in accordance with the law, did not regularly inspect the displayed and stored drugs, did not withdraw from the cabinet in time, and stopped selling drugs with questionable quali.
subjective fau.
However, considering that the parties cooperated with the case investigation and participated in public welfare activities for epidemic prevention, the amount involved in this case was small, the circumstances were relatively minor, and the parties did not actually sell expired dru.
norgestrel tablets, and a minimum fine of 100,000 yu.
At the end of April, the Qingdao Municipal Bureau of Supervision inspected and re-examined American ginseng slices purchased by a pharmaceutical compa.
The "residues of organochlorine pesticides" did not meet the regulatio.
According to the third paragraph of Article 98 of the Drug Administration Law Seven provisions are considered inferior drugs, and the bureau has punished them, including warnings; confiscation of illegal gains of 1484 yuan; confiscation of 2 packs of American ginseng slices sold illegally; and a fine of 50,000 yu.
The total amount of the above-mentioned fines and confiscations is 50,1484 yu.
A few days ago, the Henan Provincial Food and Drug Administration issued two consecutive administrative penalty decisio.
A pharmaceutical company in Henan was fined a total of 320,000 yuan for the production and sale of inferior drugs Quanxi and Puerar.
It is reported that the moisture and total ash in the whole scorpion inspection items produced and sold by the parties do not meet the requirements of the first standard of the 2020 edition of the Chinese Pharmacopoe.
According to relevant laws and regulations, the Henan Provincial Food and Drug Administration issued a warning to the company and fined 160,000 yu.
On April 22, the Guangxi Drug Administration issued a decision on administrative punishme.
The zinc sulfate oral solution sold by a pharmaceutical company in Guangxi was an inferior dr.
Because it voluntarily recalled 130 boxes of inferior drugs, it is recommended to give the parties the following administrative penalties: confiscate its sal.
The illegal gains from inferior medicines were 2,368 yuan, and 472 boxes of inferior medicines were confiscat.
For those who produce and sell inferior drugs, the illegally produced and sold drugs and illegal income will be confiscated, and the illegal production and sales will be punish.
A fine of not less than ten times but not more than 20 times the value of the drugs in question; for producing or selling counterfeit drugs, or producing or selling inferior drugs and the circumstances are serious, the legal representative, the main responsible person, the directly responsible person in charge and other responsible persons shall be fined , confiscate the income obtained from the unit during the period of the illegal act, impose a fine of not less than 30% but not more than three times the income obtained, and prohibit the production and operation of pharmaceuticals for li.
Recently, a number of pharmaceutical companies have been fined for producing and selling inferior drugs, many of which are large chains, and the illegal cost of tens of thousands of dollars has made the industry alarm bells sound aga.
Recently, an administrative punishment information released by Credit Guangzhou showed that a branch of a pharmaceutical company in Guangzhou was deemed to have failed sampling inspections of multiple batches of products such as “Korean Ginseng”, “Selected Chenpi” and “Sanqi” that were produced and so.
Inferior drugs, fined 190,000 yu.
Not long ago, a branch of a large chain pharmacy in Guangdong was fined 3,000 yuan for "failure to display medical devices and non-medical device products separately, clearly separate them, or set up clearly distinguishable labels"; Penalty information shows that the above-mentioned large chain pharmacy branch was fined 100,000 yuan for producing and selling inferior dru.
In early May, the Putian Municipal Bureau of Supervision issued an administrative penalty decision to punish a pharmacy in the Chengxiang District of Putian Ci.
The penalty decision shows that, as a drug dealer, the pharmacy failed to implement the drug inspection system and drug management quality management standards in accordance with the law, did not regularly inspect the displayed and stored drugs, did not withdraw from the cabinet in time, and stopped selling drugs with questionable quali.
subjective fau.
However, considering that the parties cooperated with the case investigation and participated in public welfare activities for epidemic prevention, the amount involved in this case was small, the circumstances were relatively minor, and the parties did not actually sell expired dru.
norgestrel tablets, and a minimum fine of 100,000 yu.
At the end of April, the Qingdao Municipal Bureau of Supervision inspected and re-examined American ginseng slices purchased by a pharmaceutical compa.
The "residues of organochlorine pesticides" did not meet the regulatio.
According to the third paragraph of Article 98 of the Drug Administration Law Seven provisions are considered inferior drugs, and the bureau has punished them, including warnings; confiscation of illegal gains of 1484 yuan; confiscation of 2 packs of American ginseng slices sold illegally; and a fine of 50,000 yu.
The total amount of the above-mentioned fines and confiscations is 50,1484 yu.
A few days ago, the Henan Provincial Food and Drug Administration issued two consecutive administrative penalty decisio.
A pharmaceutical company in Henan was fined a total of 320,000 yuan for the production and sale of inferior drugs Quanxi and Puerar.
It is reported that the moisture and total ash in the whole scorpion inspection items produced and sold by the parties do not meet the requirements of the first standard of the 2020 edition of the Chinese Pharmacopoe.
According to relevant laws and regulations, the Henan Provincial Food and Drug Administration issued a warning to the company and fined 160,000 yu.
On April 22, the Guangxi Drug Administration issued a decision on administrative punishme.
The zinc sulfate oral solution sold by a pharmaceutical company in Guangxi was an inferior dr.
Because it voluntarily recalled 130 boxes of inferior drugs, it is recommended to give the parties the following administrative penalties: confiscate its sal.
The illegal gains from inferior medicines were 2,368 yuan, and 472 boxes of inferior medicines were confiscat.
